Skip to:

Text size [+][-]  Thursday September 2 2010GLOBAL EDITION

Considered view
07 Jun 2007 15:35

Tender is the day

About Us

Breakingviews.com is the world's leading source of agenda-setting financial insight. breakingviews has 25 correspondents and columnists based in London, New York, Paris, Washington, San Francisco and Madrid. Our aim is to become the lingua franca for the global financial community. Our real-time subscription service currently reaches around 15,000 financial professionals such as investment bankers, senior corporate executives, hedge fund managers, lawyers and private equity professionals.

We reach a broader audience of nearly 4.5m investors and opinion-formers via columns in the following influential newspapers: The New York Times (USA), The Telegraph (UK), The International Herald Tribune, Le Monde (France), El Pais and Cinco Dias (Spain), Handelsblatt (Germany), La Stampa (Italy), NRC Handelsblad (Netherlands), The National (UAE), The Business Times (Singapore), Mint (India) and L’Agefi (Switzerland).

For years, confusion over the “best price” rule kept this fast and efficient takeover tool virtually off limits. SEC reforms changed that. As the $11.4bn Biomet deal shows, this can expedite deals and get round pesky proxy advisors. So is this good or bad for investors?

Sign up for a free trial to read the rest of this subscriber-only content, or if you are already a member please sign in here.

Forgotten your password? Get a password reminder.


More stories by:  Rob Cox






Share